Ephedrine for the Treatment of Congenital Myasthenia

NCT00541216 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Myasthenic Syndromes, Congenital

Interventions

DRUG: Ephedrine

Sponsor

Hadassah Medical Organization